WNT9B
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
Applikationshinweise
WNT9B Peptide is used for blocking the activity of WNT9B antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
WNT9B peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 ?L water, the concentration will be 0.5 mg/mL.
Handhabung
When reconstituted minimize freezing and thawing.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C.
Target
WNT9B
(Wingless-Type MMTV Integration Site Family, Member 9B (WNT9B))
Synonyme
WNT14B Peptide, WNT15 Peptide, WNT9B Peptide, wnt-9b Peptide, Wnt14b Peptide, Wnt15 Peptide, clf Peptide, clf1 Peptide, wnt-14b Peptide, wnt-15 Peptide, Wnt family member 9B Peptide, wingless-type MMTV integration site family member 9B L homeolog Peptide, protein Wnt-9b Peptide, wingless-type MMTV integration site family, member 9B Peptide, WNT9B Peptide, wnt9b.2.L Peptide, Wnt9b Peptide, LOC468296 Peptide, wnt9b Peptide